Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

As part of the MRC’s Clinical Research Capabilities and Technologies Initiative the MRC Weatherall Institute of Molecular Medicine (WIMM) has been award £4.9m to support the Oxford Single Cell Biology Consortium.

Credit: Dorit Hockman 

From the RDM Image Competition 2015.

An early stage lamprey embryo that has been genetically modified to express the fluorescent protein citrine. This is achieved by injecting a DNA construct, coding for citrine and an enhancer to drive its expression, into the fertilised egg along with an enzyme that assists in inserting the DNA construct into the genome. Here, citrine expression is localised to the developing neural tube, which will give rise to the brain and spinal cord.